Pharming Group (PHAR) News Today $7.36 -0.32 (-4.17%) (As of 11:56 AM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Pharming Group (NASDAQ:PHAR) Shares Gap Down - Here's What HappenedPharming Group (NASDAQ:PHAR) Shares Gap Down - Time to Sell?November 19 at 2:00 PM | marketbeat.comEncore Healthcare: Pharming the FutureNovember 11, 2024 | msn.comPharming Group N.V. (PHARM.AS)November 8, 2024 | finance.yahoo.comPharming Group to participate in November investor conferenceNovember 5, 2024 | finance.yahoo.comPharming price target lowered to EUR 1.60 from EUR 1.65 at RBC CapitalNovember 4, 2024 | markets.businessinsider.comPharming Group (NASDAQ:PHAR) Sees Large Volume Increase - Should You Buy?Pharming Group (NASDAQ:PHAR) Sees Unusually-High Trading Volume - Time to Buy?November 4, 2024 | marketbeat.comPharming Group (NASDAQ:PHAR) Shares Down 4.5% - Here's What HappenedPharming Group (NASDAQ:PHAR) Trading Down 4.5% - What's Next?November 1, 2024 | marketbeat.comPharming Group (NASDAQ:PHAR) Shares Gap Up - Still a Buy?Pharming Group (NASDAQ:PHAR) Shares Gap Up - Here's What HappenedOctober 28, 2024 | marketbeat.comPharming Group (NASDAQ:PHAR) PT Lowered to $30.00Oppenheimer dropped their price target on shares of Pharming Group from $31.00 to $30.00 and set an "outperform" rating on the stock in a research report on Monday.October 28, 2024 | marketbeat.comHC Wainwright Weighs in on Pharming Group FY2027 EarningsPharming Group (NASDAQ:PHAR - Free Report) - Stock analysts at HC Wainwright dropped their FY2027 earnings per share estimates for Pharming Group in a research report issued on Thursday, October 24th. HC Wainwright analyst J. Pantginis now anticipates that the company will post earnings per shareOctober 28, 2024 | marketbeat.comPharming Group (NASDAQ:PHAR) Sees Large Growth in Short InterestPharming Group (NASDAQ:PHAR - Get Free Report) was the target of a significant increase in short interest in the month of October. As of October 15th, there was short interest totalling 9,100 shares, an increase of 122.0% from the September 30th total of 4,100 shares. Based on an average daily volume of 7,500 shares, the short-interest ratio is presently 1.2 days.October 26, 2024 | marketbeat.comPharming Group (PHGUF) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic ...October 25, 2024 | finance.yahoo.comPositive Outlook for Pharming Group Amidst Growth Opportunities and Leadership TransitionOctober 25, 2024 | markets.businessinsider.comPharming Group (NASDAQ:PHAR) Sees Unusually-High Trading Volume - Here's WhyPharming Group (NASDAQ:PHAR) Sees Unusually-High Trading Volume - What's Next?October 25, 2024 | marketbeat.comPharming Group (NASDAQ:PHAR) Given Buy Rating at HC WainwrightHC Wainwright reaffirmed a "buy" rating and issued a $37.00 price target on shares of Pharming Group in a research note on Thursday.October 24, 2024 | marketbeat.comPharming Group (NASDAQ:PHAR) Shares Gap Down - Time to Sell?Pharming Group (NASDAQ:PHAR) Shares Gap Down - What's Next?October 24, 2024 | marketbeat.comPharming Group N.V. 2024 Q3 - Results - Earnings Call PresentationOctober 24, 2024 | seekingalpha.comPharming Group (NASDAQ:PHAR) Shares Up 4.3% - Here's WhyPharming Group (NASDAQ:PHAR) Shares Up 4.3% - Still a Buy?October 23, 2024 | marketbeat.comPharming Group (NASDAQ:PHAR) Shares Gap Up - What's Next?Pharming Group (NASDAQ:PHAR) Shares Gap Up - Still a Buy?October 22, 2024 | marketbeat.comPharming Group to Post FY2026 Earnings of $1.24 Per Share, HC Wainwright Forecasts (NASDAQ:PHAR)Pharming Group (NASDAQ:PHAR - Free Report) - Investment analysts at HC Wainwright cut their FY2026 earnings per share estimates for shares of Pharming Group in a report issued on Tuesday, October 15th. HC Wainwright analyst J. Pantginis now forecasts that the company will post earnings of $1.24 pOctober 17, 2024 | marketbeat.comAnalysts Offer Insights on Healthcare Companies: Pharming Group (PHAR) and MoonLake Immunotherapeutics (MLTX)October 16, 2024 | markets.businessinsider.comHC Wainwright Comments on Pharming Group's FY2025 Earnings (NASDAQ:PHAR)Pharming Group (NASDAQ:PHAR - Free Report) - Analysts at HC Wainwright cut their FY2025 earnings estimates for shares of Pharming Group in a research report issued on Tuesday, October 15th. HC Wainwright analyst J. Pantginis now expects that the company will earn $0.60 per share for the year, dowOctober 16, 2024 | marketbeat.comBuy Rating Affirmed for Pharming Group on Leniolisib’s Progress and Joenja’s Market ExpansionOctober 11, 2024 | markets.businessinsider.comPharming Group (NASDAQ:PHAR) Sees Strong Trading Volume - What's Next?Pharming Group (NASDAQ:PHAR) Sees Unusually-High Trading Volume - Here's WhyOctober 10, 2024 | marketbeat.comPharming Group (NASDAQ:PHAR) Shares Gap Up - Should You Buy?Pharming Group (NASDAQ:PHAR) Shares Gap Up - Should You Buy?October 7, 2024 | marketbeat.comPharming Group (NASDAQ:PHAR) Stock Price Down 4.8%Pharming Group (NASDAQ:PHAR) Stock Price Down 4.8%October 2, 2024 | marketbeat.comPharming Group shares hold Buy rating on UK drug nodSeptember 28, 2024 | investing.comPharming Group’s Joenja Garners Buy Rating Amid Regulatory Successes and Growth PotentialSeptember 26, 2024 | markets.businessinsider.comPharming Group (NASDAQ:PHAR) Rating Reiterated by HC WainwrightHC Wainwright reaffirmed a "buy" rating and issued a $37.00 price objective on shares of Pharming Group in a research note on Thursday.September 26, 2024 | marketbeat.comPharming Group (NASDAQ:PHAR) Sees Unusually-High Trading VolumePharming Group (NASDAQ:PHAR) Sees Unusually-High Trading VolumeSeptember 25, 2024 | marketbeat.comPharming Group N.V. (PHGN.F) Stock Price, News, Quote & History - Yahoo FinanceSeptember 23, 2024 | finance.yahoo.comPharming Group (NASDAQ:PHAR) Trading Down 2.6%Pharming Group (NASDAQ:PHAR) Trading Down 2.6%September 17, 2024 | marketbeat.comPharming Group (NASDAQ:PHAR) Shares Gap Up to $7.50Pharming Group (NASDAQ:PHAR) Shares Gap Up to $7.50September 16, 2024 | marketbeat.comPharming Group (NASDAQ:PHAR) Shares Down 4% Pharming Group (NASDAQ:PHAR) Trading Down 4%August 30, 2024 | marketbeat.comPharming Group (NASDAQ:PHAR) Shares Gap Up to $7.47Pharming Group (NASDAQ:PHAR) Shares Gap Up to $7.47August 29, 2024 | marketbeat.comPharming Group (PHG.DU)August 29, 2024 | uk.finance.yahoo.comPharming Group (NASDAQ:PHAR) Shares Gap Down to $8.12Pharming Group (NASDAQ:PHAR) Shares Gap Down to $8.12August 28, 2024 | marketbeat.comShort Interest in Pharming Group (NASDAQ:PHAR) Drops By 87.5%Pharming Group (NASDAQ:PHAR - Get Free Report) was the target of a significant decline in short interest in August. As of August 15th, there was short interest totalling 500 shares, a decline of 87.5% from the July 31st total of 4,000 shares. Based on an average daily volume of 7,000 shares, the days-to-cover ratio is presently 0.1 days.August 27, 2024 | marketbeat.comOriginal-Research: Pharming Group NV (von First Berlin Equity Research GmbH):...August 27, 2024 | finanznachrichten.dePharming Group (NASDAQ:PHAR) Stock Price Up 5.6%Pharming Group (NASDAQ:PHAR) Stock Price Up 5.6%August 26, 2024 | marketbeat.comPharming Group (NASDAQ:PHAR) Shares Up 5.6%Pharming Group (NASDAQ:PHAR) Trading Up 5.6%August 26, 2024 | marketbeat.comPharming Group (NASDAQ:PHAR) Shares Gap Up to $7.82Pharming Group (NASDAQ:PHAR) Shares Gap Up to $7.82August 22, 2024 | marketbeat.comPharming Group (NASDAQ:PHAR) Shares Down 3.5% Pharming Group (NASDAQ:PHAR) Trading Down 3.5%August 15, 2024 | marketbeat.comPharming Group (NASDAQ:PHAR) Shares Gap Down to $8.00Pharming Group (NASDAQ:PHAR) Shares Gap Down to $8.00August 12, 2024 | marketbeat.comPharming Group (NASDAQ:PHAR) Shares Up 4.6%Pharming Group (NASDAQ:PHAR) Shares Up 4.6%August 5, 2024 | marketbeat.comQ3 2024 Earnings Forecast for Pharming Group Issued By HC Wainwright (NASDAQ:PHAR)Pharming Group (NASDAQ:PHAR - Free Report) - Equities research analysts at HC Wainwright raised their Q3 2024 EPS estimates for Pharming Group in a research note issued on Thursday, August 1st. HC Wainwright analyst J. Pantginis now anticipates that the company will post earnings of $0.11 per shaAugust 5, 2024 | marketbeat.comPharming Group (NASDAQ:PHAR) Releases Earnings ResultsPharming Group (NASDAQ:PHAR - Get Free Report) announced its quarterly earnings results on Thursday. The company reported ($0.01) earnings per share (EPS) for the quarter. Pharming Group had a negative net margin of 4.01% and a negative return on equity of 4.61%. The company had revenue of $74.09 million during the quarter, compared to the consensus estimate of $71.95 million. During the same quarter in the prior year, the firm posted $0.02 earnings per share.August 2, 2024 | marketbeat.comPharming Group N.V. 2024 Q2 - Results - Earnings Call PresentationAugust 2, 2024 | seekingalpha.comQ4 2024 EPS Estimates for Pharming Group (NASDAQ:PHAR) Lifted by HC WainwrightPharming Group (NASDAQ:PHAR - Free Report) - HC Wainwright boosted their Q4 2024 earnings estimates for shares of Pharming Group in a research report issued on Thursday, August 1st. HC Wainwright analyst J. Pantginis now expects that the company will post earnings per share of $0.12 for the quartAugust 2, 2024 | marketbeat.comQ2 2024 Pharming Group NV Earnings Call TranscriptAugust 2, 2024 | gurufocus.com Get Pharming Group News Delivered to You Automatically Sign up to receive the latest news and ratings for PHAR and its competitors with MarketBeat's FREE daily newsletter. Email Address JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad)Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback. Get your free guide NOW before it's too late. PHAR Media Mentions By Week PHAR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PHAR News Sentiment▼1.110.47▲Average Medical News Sentiment PHAR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PHAR Articles This Week▼12▲PHAR Articles Average Week Get Pharming Group News Delivered to You Automatically Sign up to receive the latest news and ratings for PHAR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SUPN News Today CNTA News Today IRON News Today NAMS News Today MNKD News Today HRMY News Today EVO News Today GPCR News Today XNCR News Today GLPG News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PHAR) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pharming Group Please log in to your account or sign up in order to add this asset to your watchlist. Share Pharming Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
